Related Experiment Video
Updated: Feb 21, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity
William Hagopian1, Hye-Seung Lee2, Edwin Liu3
1Diabetes Programs Division, Pacific Northwest Research Institute, Seattle, Washington; wah@uw.edu.
Insights
Type 1 diabetes (T1D) autoimmunity often appears before celiac disease (CD) autoimmunity in children. Their co-occurrence is higher than expected, suggesting shared environmental or disease mechanisms.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Type 1 diabetes (T1D) and celiac disease (CD) are autoimmune disorders with shared genetic risk factors.
- Prospective data on the co-occurrence and timing of T1D and CD autoimmunities in early childhood are limited.
Purpose of the Study:
- To investigate the timing and co-occurrence of T1D and CD autoimmunities in a high-risk birth cohort.
- To identify genetic and demographic factors associated with the development of both autoimmunities.
Main Methods:
- A prospective birth cohort study of 8676 children at high genetic risk for T1D and CD, with 5891 analyzed over a median of 66 months.
- Quarterly evaluation of islet autoantibodies (IAs) and tissue transglutaminase autoantibodies (tTGAs) from 3 to 48 months of age, followed by semiannual assessments.
- Analysis of demographic factors, HLA-DR-DQ, HLA-DPB1, and 5 non-HLA genetic loci associated with T1D and CD risk.
Main Results:
- Of 5891 children, 367 developed IAs alone, 808 developed tTGAs alone, and 90 developed both.
- The co-occurrence of IAs and tTGAs was significantly higher than expected.
- IAs typically preceded tTGAs, and preceding IAs increased the risk of subsequent tTGAs (HR: 1.48).
- Increased co-occurrence was associated with T1D family history (HR: 2.80), HLA-DR3/4 (HR: 1.94), and SH2B3 rs3184504 (HR: 1.53).
Conclusions:
- In early childhood, T1D autoimmunity generally precedes CD autoimmunity.
- The observed co-occurrence of T1D and CD autoimmunities exceeds that explained by known genetic and demographic factors.
- Shared environmental or pathophysiological mechanisms likely contribute to the increased risk and co-occurrence of these autoimmune diseases.
Background And Objectives:
Few birth cohorts have prospectively followed development of type 1 diabetes (T1D) and celiac disease (CD) autoimmunities to determine timing, extent of co-occurrence, and associated genetic and demographic factors.
Methods:
In this prospective birth cohort study, 8676 children at high genetic risk of both diseases were enrolled and 5891 analyzed in median follow-up of 66 months. Along with demographic factors and HLA-DR-DQ, genotypes for HLA-DPB1 and 5 non-HLA loci conferring risk of both T1D and CD were analyzed.
Results:
Development of persistent islet autoantibodies (IAs) and tissue transglutaminase autoantibodies (tTGAs), as well as each clinical disease, was evaluated quarterly from 3 to 48 months of age and semiannually thereafter. IAs alone appeared in 367, tTGAs alone in 808, and both in 90 children. Co-occurrence significantly exceeded the expected rate. IAs usually, but not always, appeared earlier than tTGAs. IAs preceding tTGAs was associated with increasing risk of tTGAs (hazard ratio [HR]: 1.48; 95% confidence interval [CI]: 1.15-1.91). After adjusting for country, sex, family history, and all other genetic loci, significantly greater co-occurrence was observed in children with a T1D family history (HR: 2.80), HLA-DR3/4 (HR: 1.94) and single-nucleotide polymorphism rs3184504 at SH2B3 (HR: 1.53). However, observed co-occurrence was not fully accounted for by all analyzed factors.
Conclusions:
In early childhood, T1D autoimmunity usually precedes CD autoimmunity. Preceding IAs significantly increases the risk of subsequent tTGAs. Co-occurrence is greater than explained by demographic factors and extensive genetic risk loci, indicating that shared environmental or pathophysiological mechanisms may contribute to the increased risk.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications